GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Arzneiwerk AG VIDA (XTER:TLIK) » Definitions » Cyclically Adjusted PS Ratio

Arzneiwerk AG VIDA (XTER:TLIK) Cyclically Adjusted PS Ratio : 0.24 (As of May. 29, 2025)


View and export this data going back to 1998. Start your Free Trial

What is Arzneiwerk AG VIDA Cyclically Adjusted PS Ratio?

As of today (2025-05-29), Arzneiwerk AG VIDA's current share price is €0.61. Arzneiwerk AG VIDA's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2024 was €2.54. Arzneiwerk AG VIDA's Cyclically Adjusted PS Ratio for today is 0.24.

The historical rank and industry rank for Arzneiwerk AG VIDA's Cyclically Adjusted PS Ratio or its related term are showing as below:

XTER:TLIK' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.15   Med: 0.47   Max: 3.18
Current: 0.29

During the past years, Arzneiwerk AG VIDA's highest Cyclically Adjusted PS Ratio was 3.18. The lowest was 0.15. And the median was 0.47.

XTER:TLIK's Cyclically Adjusted PS Ratio is ranked better than
57.14% of 77 companies
in the Medical Distribution industry
Industry Median: 0.41 vs XTER:TLIK: 0.29

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Arzneiwerk AG VIDA's adjusted revenue per share data for the three months ended in Sep. 2024 was €2.374. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €2.54 for the trailing ten years ended in Sep. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Arzneiwerk AG VIDA Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Arzneiwerk AG VIDA's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arzneiwerk AG VIDA Cyclically Adjusted PS Ratio Chart

Arzneiwerk AG VIDA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.27 0.44 2.82 1.75 0.72

Arzneiwerk AG VIDA Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.40 0.72 0.56 0.44 0.36

Competitive Comparison of Arzneiwerk AG VIDA's Cyclically Adjusted PS Ratio

For the Medical Distribution subindustry, Arzneiwerk AG VIDA's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arzneiwerk AG VIDA's Cyclically Adjusted PS Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Arzneiwerk AG VIDA's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Arzneiwerk AG VIDA's Cyclically Adjusted PS Ratio falls into.


;
;

Arzneiwerk AG VIDA Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Arzneiwerk AG VIDA's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.61/2.54
=0.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arzneiwerk AG VIDA's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2024 is calculated as:

For example, Arzneiwerk AG VIDA's adjusted Revenue per Share data for the three months ended in Sep. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=2.374/126.1978*126.1978
=2.374

Current CPI (Sep. 2024) = 126.1978.

Arzneiwerk AG VIDA Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201412 0.741 99.543 0.939
201503 0.438 99.717 0.554
201506 0.500 100.417 0.628
201509 0.460 100.417 0.578
201512 0.799 99.717 1.011
201603 0.613 100.017 0.773
201606 0.385 100.717 0.482
201609 0.553 101.017 0.691
201612 0.641 101.217 0.799
201703 0.656 101.417 0.816
201706 0.563 102.117 0.696
201709 0.336 102.717 0.413
201712 0.800 102.617 0.984
201803 0.375 102.917 0.460
201806 0.432 104.017 0.524
201809 0.192 104.718 0.231
201812 1.224 104.217 1.482
201903 0.539 104.217 0.653
201906 0.333 105.718 0.398
201909 0.120 106.018 0.143
201912 0.274 105.818 0.327
202003 0.285 105.718 0.340
202006 0.222 106.618 0.263
202009 0.140 105.818 0.167
202012 0.169 105.518 0.202
202103 0.124 107.518 0.146
202106 0.157 108.486 0.183
202109 0.104 109.435 0.120
202112 0.159 110.384 0.182
202203 3.129 113.968 3.465
202206 3.138 115.760 3.421
202209 3.033 118.818 3.221
202212 -8.875 119.345 -9.385
202303 2.366 122.402 2.439
202306 2.471 123.140 2.532
202309 2.379 124.195 2.417
202312 -6.948 123.773 -7.084
202403 2.577 125.038 2.601
202406 2.329 125.882 2.335
202409 2.374 126.198 2.374

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Arzneiwerk AG VIDA  (XTER:TLIK) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Arzneiwerk AG VIDA Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Arzneiwerk AG VIDA's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Arzneiwerk AG VIDA Business Description

Traded in Other Exchanges
N/A
Address
Ordensmeisterstrasse 15-16, Berlin, DEU, 12099
Arzneiwerk AG VIDA is active in the pharmaceutical industry. The Pharma segment combines pharmaceutical supply with a focus on digitalization and process optimization along the pharmaceutical value chains and the management of large data volumes in the pharmaceutical industry. The company focuses on the growth area of specialty pharma in Germany and Europe which usually includes high-priced drugs for chronic, complex, or rare diseases such as oncology, neurology, autoimmune diseases, ophthalmology, hemophilia, and infectious diseases.

Arzneiwerk AG VIDA Headlines

No Headlines